Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1984 Jun;44(3):753–755. doi: 10.1128/iai.44.3.753-755.1984

Relative potency of virulent versus avirulent Legionella pneumophila for induction of cell-mediated immunity.

T W Klein, H Friedman, R Widen
PMCID: PMC263693  PMID: 6724697

Abstract

Guinea pigs were infected with either high-passage, low-virulence Legionella pneumophila or low-passage, high-virulence organisms. On an infectious dosage basis, the high-virulence organisms were much more effective at sensitizing animals for positive skin test responses and splenic lymphocyte proliferation responses to homologous antigens. These results suggest that exposure to low doses of virulent L. pneumophila can effectively prime animals for cell-mediated immune responses.

Full text

PDF
753

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berendt R. F., Young H. W., Allen R. G., Knutsen G. L. Dose-response of guinea pigs experimentally infected with aerosols of Legionella pneumophila. J Infect Dis. 1980 Feb;141(2):186–192. doi: 10.1093/infdis/141.2.186. [DOI] [PubMed] [Google Scholar]
  2. Cho S. N., Collins M. T., Reif J. S., McChesney A. E. Experimental infections of horses with Legionella pneumophila. Am J Vet Res. 1983 Apr;44(4):662–668. [PubMed] [Google Scholar]
  3. Fraser D. W., Tsai T. R., Orenstein W., Parkin W. E., Beecham H. J., Sharrar R. G., Harris J., Mallison G. F., Martin S. M., McDade J. E. Legionnaires' disease: description of an epidemic of pneumonia. N Engl J Med. 1977 Dec 1;297(22):1189–1197. doi: 10.1056/NEJM197712012972201. [DOI] [PubMed] [Google Scholar]
  4. Friedman H., Widen R., Lee I., Klein T. Cellular immunity to Legionella pneumophila in guinea pigs assessed by direct and indirect migration inhibition reactions in vitro. Infect Immun. 1983 Sep;41(3):1132–1137. doi: 10.1128/iai.41.3.1132-1137.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Helms C. M., Johnson W., Renner E. D., Hierholzer W. J., Jr, Wintermeyer L. A., Viner J. P. Background prevalence of microagglutination antibodies to Legionella pneumophila serogroups 1, 2, 3, and 4. Infect Immun. 1980 Nov;30(2):612–614. doi: 10.1128/iai.30.2.612-614.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Horwitz M. A. Cell-mediated immunity in Legionnaires' disease. J Clin Invest. 1983 Jun;71(6):1686–1697. doi: 10.1172/JCI110923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Johnson W., Pesanti E., Elliott J. Serospecificity and opsonic activity of antisera to Legionella pneumophila. Infect Immun. 1979 Nov;26(2):698–704. doi: 10.1128/iai.26.2.698-704.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kirby B. D., Snyder K. M., Meyer R. D., Finegold S. M. Legionnaires' disease: report of sixty-five nosocomially acquired cases of review of the literature. Medicine (Baltimore) 1980 May;59(3):188–205. [PubMed] [Google Scholar]
  9. McDade J. E., Shepard C. C. Virulent to avirulent conversion of Legionnaires' disease bacterium (Legionella pneumophila)--its effect on isolation techniques. J Infect Dis. 1979 Jun;139(6):707–711. doi: 10.1093/infdis/139.6.707. [DOI] [PubMed] [Google Scholar]
  10. Orrison L. H., Cherry W. B., Fliermans C. B., Dees S. B., McDougal L. K., Dodd D. J. Characteristics of environmental isolates of Legionella pneumophila. Appl Environ Microbiol. 1981 Jul;42(1):109–115. doi: 10.1128/aem.42.1.109-115.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Pendlebury W. W., Perl D. P., Winn W. C., Jr, McQuillen J. B. Neuropathologic evaluation of 40 confirmed cases of Legionella pneumonia. Neurology. 1983 Oct;33(10):1340–1344. doi: 10.1212/wnl.33.10.1340. [DOI] [PubMed] [Google Scholar]
  12. Plouffe J. F., Baird I. M. Lymphocyte transformation to Legionella pneumophila. J Clin Lab Immunol. 1981 May;5(3):149–152. [PubMed] [Google Scholar]
  13. Plouffe J. F., Para M. F., Maher W. E., Hackman B., Webster L. Subtypes of Legionella pneumophila serogroup 1 associated with different attack rates. Lancet. 1983 Sep 17;2(8351):649–650. doi: 10.1016/s0140-6736(83)92531-x. [DOI] [PubMed] [Google Scholar]
  14. Rolstad B., Berdal B. P. Immune defenses against Legionella pneumophila in rats. Infect Immun. 1981 May;32(2):805–812. doi: 10.1128/iai.32.2.805-812.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Widen R., Lee I., Klein T., Friedman H. Blastogenic responsiveness of spleen cells from guinea pigs sensitized to Legionella pneumophila antigens. Proc Soc Exp Biol Med. 1983 Sep;173(4):547–552. doi: 10.3181/00379727-173-41685. [DOI] [PubMed] [Google Scholar]
  16. Wilkinson H. W., Cruce D. D., Broome C. V. Validation of Legionella pneumophila indirect immunofluorescence assay with epidemic sera. J Clin Microbiol. 1981 Jan;13(1):139–146. doi: 10.1128/jcm.13.1.139-146.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Zuravleff J. J., Yu V. L., Shonnard J. W., Rihs J. D., Best M. Legionella pneumophila contamination of a hospital humidifier. Demonstration of aerosol transmission and subsequent subclinical infection in exposed guinea pigs. Am Rev Respir Dis. 1983 Oct;128(4):657–661. doi: 10.1164/arrd.1983.128.4.657. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES